The average number of persons, including directors, employed by the company during the year was as follows:

During the year ended 30th September 2024, some transactions were recorded incorrectly in error. The effects of these transactions being recorded correctly are as follows:

• Fixed Assets has decreased by £488

• Creditors has increased by £19,414

• Share Capital has increased by £1

• Profit and Loss for the year is restated to a £18,627 loss in the year from a £1,276 profit. The change consists of Cost of Sales increasing by £3,361 and Administrative Expenses increasing by £16,542.

• There are no additional tax charges as a result of this restatement.

Blue Beagle Bio Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Translation And Innovation Hub, 84 Wood Lane, London, W12 0BZ.

For the year ended 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime', and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true